From the foregoing it is obvious that the defects in the ability to excrete sodium and water in patients with refractory edema are multiple. It is the purpose of the present st-udy to reinvestigate some of these defects in sodium and water metabolism. We chose to study over a prolonged period the relationships between the excretion of sodium and water under the influence of agents shown to block the renal action of aldosterone and the adrenal synthesis of aldosterone, and the relationship of the glueocorticoids to the excretion of sodium and water. Experiments were also performed to obtain further information on whether the locus of action of the glucocorticoids on the excretion of water was at the level of the posterior pituitary or at the renal tubular level.
tic measures. In some patients refractoriness develops only after a period of favorable response to therapy, while in others it appears at the outset. While hemodynamic factors, such as elevated venous pressure, decreased cardiac output, decreased glomerular filtration rate and renal blood flow, and hypoproteinemia, contribute to or may initiate salt and water retention, these factors, important as they are in edema formation, alone cannot explain the development of edema.
Increased aldosterone activity is a wellrecognized accompaniment of edema states, and the effect of altered hemodynamics and electrolyte patterns, on aldosterone activity has been described by many investigators. [1] [2] [3] [4] The advent of the aldosterone antagonists has provided a useful tool for the study of refractory edema. Despite their ability to block the action of aldosterone in the renal tubule" however, therapeutic failures are not unusual. The lack of a consistently favorable response suggests that, apart from hemodynamic considerations, increased aldosterone activity mnay not explain fully the development of refractory edema.
Patients with refractory edema commonly develop hyponatremia. In some individuals, particularly with cardiac edema, this may be related to From the foregoing it is obvious that the defects in the ability to excrete sodium and water in patients with refractory edema are multiple. It is the purpose of the present st-udy to reinvestigate some of these defects in sodium and water metabolism. We chose to study over a prolonged period the relationships between the excretion of sodium and water under the influence of agents shown to block the renal action of aldosterone and the adrenal synthesis of aldosterone, and the relationship of the glueocorticoids to the excretion of sodium and water. Experiments were also performed to obtain further information on whether the locus of action of the glucocorticoids on the excretion of water was at the level of the posterior pituitary or at the renal tubular level. 
Results
In tables 1 and 2 are given the data relating to the effects of spironolactone, hydrochlorothiazide, prednisone, Su4885, and ACTH on the excretion of sodium, potassium, and urine, and on body weight. The range of effect on these moieties varied widely from patient to patient and even in repeated studies on the same patient. These variations may have been due, in part, to changes in the clinical status of the patient and, in part, to variations in the dosage schedules. Spironolactone and hydrochlorothiazide administered singly, usually produced an increase in the exeretion of sodium, and to a smaller extent an increase in urine volume. The administration of prednisone concomitant with spironolactone, and in the single study with hydrochlorothiazide (patient A.M.), produced a more distinct rise in both sodium excretion and urine volume. Whenever prednisone was added to any therapeutic regimen, the urine volume was distinctly higher than the control, and weight loss usually occurred. Prednisone, administered alone, enhanced the output of urine without altering the excretion of sodium and without inducing weight loss.
The administration of spironolactone and hydrochlorothiazide together tended to produce greater natriuresis and urine volume than either agent separately, but not so great as when either agent was combined with prednisone. Su4885 combination with spironolactone or spironolactone and prednisone failed to enhance sodium excretion in all patients except J.C. In two patients (J.C. and A.D.) the addition of ACTH to a regimen consisting of spironolactone, Su4885, and prednisone sharply reduced the excretion of sodium with only a minor reduction in urine volume.
In table 3 are tabulated the effects of spironolactone as a diuretic. In only four instances tParacentesis performed on last day of period. C, control; S, spiroinolactone; P, prednisone; H, hydrochlorothiazide; Su, Su4885; A, ACTH. *Patient with high value was receiving supplements of potassium chloride, 6 Gm./day.
(H.B.#1, 600 mg., H.B.#2, 800 mg., J.C., A.L.) was there distinct sodium and weight loss exceeding that of the initial control. In six instances (H.B.#1, 400 mg., H.B.#2, 400 mg., F.W.#2, 1,000 mg., M.C.#1 and #2, and A.TL.) sodium excretion was increased distinctly over the control, but no effective weight loss was noted; and in four of these six periods, no particular increase in urine volume developed. in sodium excretion, an effect not observed later on a smaller dose ( fig. 2) . Vasopressin in oil, 5 units daily for 2 days, during prednisone and spironolactone therapy, induced a sharp fall in urine volume.
Three points are of significance in figure 3 . First, spironolactone increased the excretion of sodium mildly without a comparable effect on urine volume. Second, spironolactone plus prednisone induced a sharp rise in sodium excretion, urine volume, and distinct weight loss. Finally, with prednisone alone sodium excretion fell sharply and weight loss ceased, while urine volume was well sustained. Figure 4 illustrates the effects of prednisone and spironolactone on a patient receiving hydrochlorothiazide continuously. Supplementary potassium was increased from 3 to 6 Gm. because of a fall in the concentration of potassium in the serum. Both prednisone and spironolactone increased the excretion of sodium and water, and induced weight loss, whereas hydrochlorothiazide alone, although producing some natriuresis, did not augment water excretion or weight loss.
In Although other diuretics such as the thiazides, act by blocking renal tubular reabsorption of sodium unrelated to aldosterone activity, the diuretic, in contrast to the natriuretic efficacy still depends on how much sodium reabsorption is bloeked. The thiazides as well as spironolactone increase sodium excretion without an increase in free water Mins. Mins.
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clearance, in contrast to the mercurials which increase free water clearance as well as sodium exeretion. '7-19 It is clear that prednisone exerts a dual effect in the patients studied: on the excretion of water and on the excretion of sodium. The effect on sodium is apparent only when an agent blocking sodium reabsorption is used concomitantly, and appears, therefore, to potentiate the natriuretic effect of a diuretic. By contrast, when used alone, prednisone increases only the excretion of water. These observations suggest that the glueocorticoid 21 M.X A j It is considered possible that renal aldo;sterone-stimulating hormone acts only under more intense stimuli to edema formation.
